Concepedia

Akash Patnaik

AP

45

Publications

4.2K

Citations

27

H-Index

2000

Active since

Affiliations

University of Chicago(Current)

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

Cornell University

University of California, San Francisco

Akash Patnaik is an author at University of Chicago specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2000–2025

45

Publications

45

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

Wassim Abida, Akash Patnaik, David Campbell et al. · Journal of Clinical Oncology · 2020 · 655 citations · Full text

Pan-cancer image-based detection of clinically actionable genetic alterations

Jakob Nikolas Kather, Lara R. Heij, Heike I. Grabsch et al. · Nature Cancer · 2020 · 600 citations · Full text

, , +9

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Padmanee Sharma, Russell K. Pachynski, Vivek Narayan et al. · Cancer Cell · 2020 · 371 citations

, , +8

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology · 2021 · 352 citations · Full text

Ubiquitin is part of the retrovirus budding machinery

Akash Patnaik, Vincent Chau, John W. Wills · Proceedings of the National Academy of Sciences · 2000 · 290 citations · Full text

, , +10

Rows per page

1–5 of 45